Patients with CLL have significantly reduced response to COVID-19 vaccine May 16, 2021CLLCOVID-19 Updates
Pediatric cancer survivors at risk for opioid misuseMay 5, 2021ALLPatient & Survivor CareOpioid Resource CenterPediatricsAMLB Cell LymphomaCLL
CLL patients: Diagnostic difficulties, treatment confusion with COVID-19April 19, 2021CLLCOVID-19 Updates
Don’t delay: Cancer patients need both doses of COVID vaccineMarch 15, 2021Patient & Survivor CareAggressive LymphomasB Cell LymphomaT Cell LymphomasMultiple MyelomaMantle Cell LymphomaIndolent Lymphoma
New inhibitor shows promise in previously failed B-cell malignanciesMarch 12, 2021CLLMantle Cell Lymphoma
CLL, MBL had lower response rates to flu vaccination, compared with healthy adultsFebruary 9, 2021CLL
Synthetic lethality: Triple combination is a viable strategy for B-cell malignanciesDecember 11, 2020B Cell LymphomaDLBCLCLL
Ibrutinib associated with decreased circulating malignant cells and restored T-cell function in CLL patientsNovember 10, 2020CLL
